Expression, purification, and PC1-mediated processing of (H10D, P28K, and K29P)-human proinsulin

Protein Expression and Purification

Volumn 27, Issue 2, 2003, Pages 210-219

  Mackin, Robert B ^a   Choquette, Meredith H ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ASPARTIC ENDOPEPTIDASES; BASE SEQUENCE; CHROMATOGRAPHY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISULFIDES; DNA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PEPTIDES; PLASMIDS; PROINSULIN; PROPROTEIN CONVERTASES; PROTEIN FOLDING; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TIME FACTORS;

BACTERIA (MICROORGANISMS);

EID: 0037296164     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1046-5928(02)00643-5     Document Type: Article

References (26)

1. D.J. Cowley, R.B. Mackin, Expression, purification and characterization of recombinant human proinsulin, FEBS Lett. 402 (1997) 124-130.
2. R.B. Mackin, Streamlined procedure for the production of normal and altered versions of recombinant human proinsulin, Protein Expr. Purif. 15 (1999) 308-313.
3. 13C labeling with application to protein design, Biochemistry 30 (1991) 7373-7389.
4. V.P. Saxena, D.B. Wetlaufer, Formation of three-dimensional structure in proteins. I. Rapid nonenzymic reactivation of reduced lysozyme, Biochemistry 9 (1970) 5015-5023.
5. A.K. Ahmed, S.W. Schaffer, D.B. Wetlaufer, Nonenzymic reactivation of reduced bovine pancreatic ribonuclease by air oxidation and by glutathione oxidoreduction buffers, J. Biol. Chem. 250 (1975) 8477-8482.
6. P.T. Wingfield, I. Palmer, S.-M. Liang, Folding and purification of insoluble (inclusion-body) proteins from Escherichia coli, in: J.E. Coligan, B.M. Dunn, H.L. Ploegh, D.W. Speicher, P.T. Wingfield (Eds.), Current Protocols in Protein Science, John Wiley and Sons, New York, 1998, pp. 6.5.1-6.5.27.
7. E. De Bernardez Clark, E. Schwarz, R. Rudolph, Inhibition of aggregation side reactions during in vitro protein folding, Methods Enzymol. 309 (1999) 217-236.
8. A. Zhou, G. Webb, X. Zhu, D.F. Steiner, Proteolytic processing in the secretory pathway, J. Biol. Chem. 274 (1999) 20745-20748.
9. N.G. Seidah, M. Chrétien, Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides, Brain Res. 848 (1999) 45-62.
10. L. Muller, I. Lindberg, The cell biology of the prohormone convertases PC1 and PC2, Prog. Nucleic Acid Res. Mol. Biol. 63 (2000) 69-108.
11. D.L. Bennett, E.M. Bailyes, E. Nielsen, P.C. Guest, N.G. Rutherford, S.D. Arden, J.C. Hutton, Identification of the type 2 proinsulin processing endopeptidase as PC2, a member of the eukaryote subtilisin family, J. Biol. Chem. 267 (1992) 15229-15236.
12. E.M. Bailyes, K.I.J. Shennan, A.J. Seal, S.P. Smeekens, D.F. Steiner, J.C. Hutton, K. Docherty, A member of the eukaryotic subtilisin family (PC3) has the enzymic properties of the type 1 proinsulin-converting endopeptidase, Biochem. J. 285 (1992) 391-394.
13. M.R. Schiller, A.B. Kohn, L.M. Mende-Mueller, K. Miller, V.Y.H. Hook, Expression of recombinant pro-neuropeptide Y, proopiomelanocortin, and proenkephalin: relative processing by 'prohormone thiol protease' (PTP), FEBS Lett. 382 (1996) 6-10.
14. V.Y.H. Hook, K. Moran, R. Kannan, A. Kohn, M.O. Lively, A. Azaryan, M. Schiller, K. Miller, High-level expression of the prohormones proenkephalin, pro-neuropeptide Y, proopiomelanocortin, and β-protachykinin for in vitro prohormone processing, Protein Expr. Purif. 10 (1997) 80-88.
15. R.G. Hammonds Jr., P. McKay, G.A. Winslow, H. Diefenbach-Jagger, V. Grill, J. Glatz, C.P. Rodda, J.M. Moseley, W.I. Wood, T.J. Martin, Purification and characterization of recombinant human parathyroid hormone-related protein, J. Biol. Chem. 264 (1989) 14806-14811.
16. V.Y.H. Hook, D. Burton, S. Yasothornsrikul, R.H. Hastings, L.J. Deftos, Proteolysis of proPTHrP(1-141) by "prohormone thiol protease" at multibasic residues generates PTHrP-related peptides: implications for PTHrP peptide production in lung cancer cells, Biochem. Biophys. Res. Commun. 285 (2001) 932-938.
17. B.M. Frank, J.M. Pettee, R.E. Zimmerman, P.J. Burck, The production of human proinsulin and its transformation to human insulin and C-peptide, in: D.H. Rich, E. Gross (Eds.), Peptides: Synthesis-Structure-Function. Proceedings of the Seventh American Peptide Symposium, Pierce Chemical Company, Rockford, IL, 1981, pp. 729-738.
18. R.E. Chance, J.A. Hoffmann, E.P. Kroeff, M.G. Johnson, E.W. Schirmer, W.W. Bromer, M.J. Ross, R. Wetzel, The production of human insulin using recombinant DNA technology and a new chain combination procedure, in: D.H. Rich, E. Gross (Eds.), Peptides: Synthesis-Structure-Function: Proceedings of the Seventh American Peptide Symposium, Pierce Chemical, Rockford, IL, 1981, pp. 721-728.
19. J.S. Patrick, A.L. Lagu, Determination of recombinant human proinsulin fusion protein produced in Escherichia coli using oxidative sulfitolysis and two-dimensional HPLC, Anal. Chem. 64 (1992) 507-511.
20. H. Berg, M. Walter, L. Mauch, J. Seissler, W. Northemann, Recombinant human preproinsulin. Expression, purification and reaction with insulin autoantibodies in sera from patients with insulin-dependent diabetes mellitus, J. Immunol. Meth. 164 (1993) 221-231.
21. J. Olmos, N. Cruz, M. Sánchez, M. López, P. Balbás, G. Gosset, F. Valle, F. Bolivar, Production in Escherichia coli of a rat chimeric proinsulin polypeptide carrying human A and B chains and its preparative chromatography, J. Biotech. 38 (1994) 89-96.
22. R.V. Tikhonov, S.E. Pechenov, I.A. Belacheu, S.A. Yakimov, V.E. Klyushnichenko, E.F. Boldireva, V.G. Korobko, H. Tunes, J.E. Thiemann, L. Vilela, A.N. Wulfson, Recombinant human insulin. VIII. Isolation of fusion protein-S-sulfonate, biotechnological precursor of human insulin, from the biomass of transformed Escherichia coli cells, Protein Expr. Purif. 21 (2001) 176-182.
23. M.A. Weiss, B.H. Frank, I. Khait, A. Pekar, R. Heiney, S.E. Shoelson, L.J. Neuringer, NMR and photo-CIDNP studies of human proinsulin and prohormone processing intermediates with application to endopeptidase recognition, Biochemistry 29 (1990) 8389-8401.
24. J. Brange, U. Ribel, J.F. Hansen, G. Dodson, M.T. Hansen, S. Havelund, S.G. Melberg, F. Norris, K. Norris, L. Snel, A.R. Sørensen, H.O. Voigt, Monomeric insulins obtained by protein engineering and their medical implications, Nature 333 (1988) 679-682.
25. M. Furuta, R. Carroll, S. Martin, H.H. Swift, M. Ravazzola, L. Orci, D.F. Steiner, Incomplete processing of proinsulin to insulin accompanied by elevation of des-31,32 proinsulin intermediates in islets of mice lacking active PC2, J. Biol. Chem. 273 (1998) 3431-3437.
26. R.J. Siezen, J.W.M. Creemers, W.J.M. Van de Ven, Homology modelling of the catalytic domain of human furin - a model for the eukaryotic subtilisin-like proprotein convertases, Eur. J. Biochem. 222 (1994) 255-266.